Douglas Ray McDonald, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Deficiency Syndromes | 5 | 2022 | 548 | 1.470 |
Why?
|
Dermatitis, Atopic | 3 | 2022 | 731 | 0.910 |
Why?
|
Eosinophilic Esophagitis | 3 | 2024 | 199 | 0.850 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 4 | 2010 | 76 | 0.780 |
Why?
|
Guanine Nucleotide Exchange Factors | 6 | 2016 | 569 | 0.700 |
Why?
|
Eosinophilia | 1 | 2022 | 557 | 0.570 |
Why?
|
Immunity, Mucosal | 1 | 2019 | 484 | 0.520 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 668 | 0.500 |
Why?
|
Toll-Like Receptors | 6 | 2010 | 575 | 0.420 |
Why?
|
I-kappa B Proteins | 3 | 2010 | 210 | 0.420 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2012 | 19 | 0.410 |
Why?
|
Gastroesophageal Reflux | 1 | 2019 | 821 | 0.400 |
Why?
|
Immunity, Innate | 4 | 2020 | 3044 | 0.390 |
Why?
|
Food Hypersensitivity | 1 | 2019 | 726 | 0.380 |
Why?
|
I-kappa B Kinase | 2 | 2010 | 249 | 0.380 |
Why?
|
NF-kappa B | 4 | 2018 | 2475 | 0.370 |
Why?
|
Immunologic Factors | 1 | 2020 | 1589 | 0.360 |
Why?
|
Sinusitis | 1 | 2019 | 991 | 0.350 |
Why?
|
Ectodermal Dysplasia | 2 | 2007 | 106 | 0.330 |
Why?
|
5' Untranslated Regions | 1 | 2010 | 251 | 0.320 |
Why?
|
T-Lymphocytes | 4 | 2020 | 10203 | 0.270 |
Why?
|
Codon, Nonsense | 1 | 2007 | 284 | 0.260 |
Why?
|
Lymphocyte Activation | 4 | 2018 | 5478 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3094 | 0.250 |
Why?
|
Transplantation Tolerance | 1 | 2010 | 620 | 0.250 |
Why?
|
Genetic Diseases, Inborn | 1 | 2010 | 604 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3216 | 0.250 |
Why?
|
Th17 Cells | 1 | 2012 | 794 | 0.250 |
Why?
|
Toll-Like Receptor 9 | 2 | 2018 | 193 | 0.230 |
Why?
|
Receptors, Interferon | 1 | 2024 | 115 | 0.220 |
Why?
|
STAT3 Transcription Factor | 3 | 2018 | 872 | 0.210 |
Why?
|
Interleukin-13 | 1 | 2024 | 392 | 0.200 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2010 | 2549 | 0.190 |
Why?
|
Microglia | 3 | 2003 | 1357 | 0.190 |
Why?
|
Adaptive Immunity | 2 | 2020 | 724 | 0.180 |
Why?
|
Pandemics | 2 | 2020 | 8663 | 0.180 |
Why?
|
Antibody-Dependent Enhancement | 1 | 2020 | 15 | 0.180 |
Why?
|
Asthma | 1 | 2019 | 6229 | 0.180 |
Why?
|
Virus Diseases | 1 | 2006 | 716 | 0.180 |
Why?
|
Mutation | 9 | 2024 | 30006 | 0.170 |
Why?
|
Down-Regulation | 1 | 2006 | 2915 | 0.160 |
Why?
|
Monocytes | 3 | 2003 | 2570 | 0.160 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2020 | 147 | 0.160 |
Why?
|
B-Lymphocytes | 4 | 2018 | 4744 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 328 | 0.150 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 1998 | 55 | 0.150 |
Why?
|
Disease Susceptibility | 3 | 2022 | 1790 | 0.150 |
Why?
|
Immunization, Passive | 1 | 2020 | 617 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2016 | 5667 | 0.150 |
Why?
|
Common Variable Immunodeficiency | 1 | 2018 | 100 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 2 | 2020 | 577 | 0.140 |
Why?
|
Heterozygote | 1 | 2024 | 2778 | 0.140 |
Why?
|
Cytokines | 6 | 2016 | 7386 | 0.140 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2012 | 583 | 0.140 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.140 |
Why?
|
Immune System | 1 | 2022 | 792 | 0.140 |
Why?
|
Amyloid beta-Peptides | 3 | 2003 | 3840 | 0.140 |
Why?
|
Phosphorylation | 7 | 2018 | 8303 | 0.130 |
Why?
|
Superoxides | 1 | 1997 | 388 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 619 | 0.120 |
Why?
|
Receptors, Immunologic | 2 | 2020 | 1408 | 0.120 |
Why?
|
Proton Pump Inhibitors | 1 | 2019 | 534 | 0.120 |
Why?
|
Receptors, IgG | 1 | 1997 | 558 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1998 | 1240 | 0.110 |
Why?
|
Interferon-alpha | 3 | 2020 | 907 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1182 | 0.100 |
Why?
|
Child | 12 | 2020 | 80134 | 0.100 |
Why?
|
Meningomyelocele | 1 | 2012 | 172 | 0.090 |
Why?
|
STAT1 Transcription Factor | 1 | 2012 | 340 | 0.090 |
Why?
|
Gelatin | 1 | 2012 | 221 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 3 | 2018 | 1837 | 0.090 |
Why?
|
Chimerism | 1 | 2010 | 155 | 0.080 |
Why?
|
Hemostatics | 1 | 2012 | 240 | 0.080 |
Why?
|
Child, Preschool | 9 | 2020 | 42217 | 0.080 |
Why?
|
Gene Expression | 2 | 2020 | 7567 | 0.080 |
Why?
|
RNA Splice Sites | 1 | 2010 | 210 | 0.080 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 307 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2003 | 2426 | 0.080 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2010 | 173 | 0.080 |
Why?
|
Peptide Fragments | 3 | 2003 | 5103 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2813 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1521 | 0.080 |
Why?
|
Lymphopenia | 1 | 2010 | 281 | 0.080 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 897 | 0.080 |
Why?
|
Vaccinia | 1 | 2007 | 70 | 0.070 |
Why?
|
Lectins, C-Type | 1 | 2010 | 585 | 0.070 |
Why?
|
Chemotaxis | 1 | 2010 | 598 | 0.070 |
Why?
|
Homozygote | 2 | 2014 | 1775 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1831 | 0.070 |
Why?
|
Humans | 26 | 2024 | 761098 | 0.070 |
Why?
|
Immunity, Active | 1 | 2006 | 58 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 431 | 0.070 |
Why?
|
Vaccinia virus | 1 | 2007 | 329 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2012 | 1361 | 0.060 |
Why?
|
Scoliosis | 1 | 2012 | 790 | 0.060 |
Why?
|
Anaphylaxis | 1 | 2012 | 758 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10514 | 0.060 |
Why?
|
Small Molecule Libraries | 1 | 2010 | 731 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2010 | 1002 | 0.060 |
Why?
|
Receptors, Cell Surface | 2 | 2004 | 2802 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4340 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2010 | 1591 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2007 | 1250 | 0.060 |
Why?
|
Antigens, CD | 3 | 2010 | 4008 | 0.060 |
Why?
|
Bacterial Infections | 2 | 2010 | 1390 | 0.050 |
Why?
|
Receptors, Lipoprotein | 1 | 2003 | 88 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2014 | 2726 | 0.050 |
Why?
|
Spinal Fusion | 1 | 2012 | 1294 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4822 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2010 | 2138 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 88271 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4111 | 0.050 |
Why?
|
Phosphotyrosine | 2 | 2003 | 455 | 0.050 |
Why?
|
Neutrophils | 2 | 2012 | 3763 | 0.050 |
Why?
|
Exons | 1 | 2006 | 2380 | 0.040 |
Why?
|
Infant | 3 | 2019 | 36164 | 0.040 |
Why?
|
Bone Marrow | 1 | 2010 | 2911 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2024 | 1154 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2014 | 4574 | 0.040 |
Why?
|
Gene Deletion | 1 | 2007 | 2656 | 0.040 |
Why?
|
Animals | 8 | 2022 | 168083 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2012 | 11505 | 0.040 |
Why?
|
Th2 Cells | 1 | 2024 | 1071 | 0.040 |
Why?
|
Budesonide | 1 | 2019 | 158 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2020 | 336 | 0.040 |
Why?
|
Female | 12 | 2024 | 392458 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4189 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2018 | 22157 | 0.040 |
Why?
|
Male | 11 | 2024 | 360675 | 0.040 |
Why?
|
Stilbenes | 1 | 1998 | 155 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2018 | 238 | 0.040 |
Why?
|
Enzyme Precursors | 1 | 1997 | 167 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2018 | 704 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2004 | 2200 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2007 | 18926 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 501 | 0.030 |
Why?
|
Signal Transduction | 4 | 2020 | 23415 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2010 | 12743 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2012 | 14393 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 681 | 0.030 |
Why?
|
Antiviral Agents | 2 | 2020 | 3048 | 0.030 |
Why?
|
Tyrosine | 1 | 1998 | 1422 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3696 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1470 | 0.030 |
Why?
|
Pedigree | 2 | 2014 | 4537 | 0.030 |
Why?
|
Herpesviridae Infections | 1 | 2014 | 269 | 0.030 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2012 | 55 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5870 | 0.030 |
Why?
|
Proteins | 2 | 2004 | 5993 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1998 | 3577 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 64670 | 0.030 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2012 | 87 | 0.020 |
Why?
|
Consanguinity | 1 | 2014 | 457 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4510 | 0.020 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2014 | 229 | 0.020 |
Why?
|
Mice | 6 | 2012 | 81324 | 0.020 |
Why?
|
Protein Kinases | 1 | 1998 | 1607 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2012 | 6198 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2010 | 262 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2012 | 535 | 0.020 |
Why?
|
Kinetics | 1 | 1997 | 6312 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1997 | 6123 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2010 | 363 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1867 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8000 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 637 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1997 | 2443 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2014 | 1505 | 0.020 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2007 | 47 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1761 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2709 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1997 | 2870 | 0.020 |
Why?
|
Aged | 1 | 2019 | 169266 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4538 | 0.020 |
Why?
|
Adult | 2 | 2019 | 221083 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7844 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1602 | 0.020 |
Why?
|
Middle Aged | 1 | 2019 | 220835 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1331 | 0.010 |
Why?
|
Immunity | 1 | 2010 | 996 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6507 | 0.010 |
Why?
|
Integrin alpha6beta1 | 1 | 2003 | 19 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 255 | 0.010 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2004 | 140 | 0.010 |
Why?
|
Scavenger Receptors, Class B | 1 | 2003 | 85 | 0.010 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2003 | 89 | 0.010 |
Why?
|
Receptors, Scavenger | 1 | 2003 | 123 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10421 | 0.010 |
Why?
|
Immunoglobulin Class Switching | 1 | 2004 | 289 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2007 | 821 | 0.010 |
Why?
|
Rats | 1 | 1998 | 23713 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 585 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2004 | 1128 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1429 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 22129 | 0.010 |
Why?
|
Leukocytes | 1 | 2007 | 2024 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2003 | 3090 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2004 | 2455 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54419 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 2864 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5776 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3210 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7405 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2003 | 4933 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11856 | 0.010 |
Why?
|
Cell Line | 1 | 2003 | 15542 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18217 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9455 | 0.000 |
Why?
|